IRIS-Onyx Cohort in the IRIS-DES Registry

NCT02593994 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2026-01-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Conditions

Interventions

DEVICE

Onyx Drug Eluting Stent group

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER
  • Medtronic Korea Co., Ltd.

    collaborator UNKNOWN
  • Seung-Jung Park

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2026-12-31
Completion
2030-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593994 on ClinicalTrials.gov